State Of Wisconsin Investment Board Kiniksa Pharmaceuticals, Ltd. Transaction History

State Of Wisconsin Investment Board

$36.2 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.63 - $21.74 $997,329 - $1.23 Million	56,570 Added 69.77%	137,647 $2.72 Million
Q4 2023 Feb 12, 2024	BUY	$14.37 - $19.07 $808,772 - $1.07 Million	56,282 Added 226.99%	81,077 $1.42 Million
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $37,100 - $55,024	-2,724 Reduced 9.9%	24,795 $430,000
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $23,239 - $36,684	-2,226 Reduced 7.48%	27,519 $387,000
Q1 2023 May 15, 2023	SELL	$10.7 - $15.79 $4,547 - $6,710	-425 Reduced 1.41%	29,745 $320,000
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $37,902 - $56,588	3,319 Added 12.36%	30,170 $451,000
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $16,123 - $22,153	-1,652 Reduced 5.8%	26,851 $345,000
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $56,262 - $84,468	7,403 Added 35.09%	28,503 $276,000
Q1 2022 May 13, 2022	BUY	$9.3 - $12.37 $196,230 - $261,006	21,100 New	21,100 $210,000
Q2 2021 Aug 12, 2021	SELL	$13.22 - $19.09 $657,034 - $948,773	-49,700 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $73,392 - $105,468	-4,400 Reduced 8.13%	49,700 $920,000
Q4 2020 Feb 03, 2021	BUY	$14.8 - $21.15 $31,080 - $44,415	2,100 Added 4.04%	54,100 $956,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $442,611 - $742,923	29,100 Added 127.07%	52,000 $797,000
Q2 2020 Aug 12, 2020	BUY	$15.08 - $26.0 $21,112 - $36,400	1,400 Added 6.51%	22,900 $583,000
Q1 2020 May 06, 2020	BUY	$11.0 - $19.76 $236,500 - $424,840	21,500 New	21,500 $333,000
Q3 2019 Nov 12, 2019	SELL	$8.15 - $15.88 $140,995 - $274,724	-17,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $228,360 - $352,747	17,300 New	17,300 $234,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.89M

Call Options Held

Put Options Held

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $862M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account